Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines ; volume:10 ; number:1 ; day:31 ; month:7 ; year:2012 ; pages:1-7 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (31.7.2012), 1-7, 12.2012

Creator: Accolla, Roberto S.

Contributor: Tosi, Giovanna
SpringerLink (Online service)

DOI: 10.1186/1479-5876-10-154

URN: urn:nbn:de:1111-2016041441065

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Accolla, Roberto S.
Tosi, Giovanna
SpringerLink (Online service)

Other Objects (12)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Vaccines targeting the neovasculature of tumors

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

Semi-allogeneic vaccines and tumor-induced immune tolerance

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Advances and applications of RNA vaccines in tumor treatment

Developing anti-tumor vaccines : antigens and antigen-presenting cells

Cancer vaccines: shared tumor antigens return to the spotlight

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)

Related objects

Reset password